Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin-IPV replacement vaccination trial
ChiCTR1800016767Phase 4Recruiting
- Sponsor
- Beijing Center for Disease Control and Prevention
- Start
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trivalent inactivated polio vaccine and Sabin strain inactivated poliovirus vaccine in poliomyelitis (2 arms), sponsored by Beijing Center for Disease Control and Prevention. Primary endpoints: Poliovirus type I seroconversion rate, Poliovirus type II seroconversion rate and 4 more. Started Mar 2018; status: recruiting.
02
Drugs
trivalent inactivated polio vaccineSabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ChiCTR1800016767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016767.